Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mycobacterium avium subspecies paratuberculosis (MAP) antigens are molecular components derived from MAP, the causative agent of Johne's disease in ruminants. These antigens, including proteins like GroES, 32-kDa secreted protein, and 34-kDa cell wall antigen/protease, are used in diagnostic assays (ELISA) to detect anti-MAP antibodies, aiding in veterinary surveillance. There is also concern about zoonotic transmission and a possible link to human diseases like Crohn’s.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mycobacterium avium subspecies paratuberculosis Antigen (None).